Seattle / Dresden / Dallas / Helsinki / Birmingham / Boston / Baltimore / La Jolla / Heidelberg / Cambridge / Biology / London / San Diego / Lincoln / /
Company
1Cenix BioScience GmbH / European Molecular Biology Laboratory / /
Country
Germany / Netherlands / United States / United Kingdom / Finland / / /
EntertainmentAwardEvent
Jussi / /
Facility
Massachusetts General Hospital / UT Southwestern Medical Center / Farber Cancer Institute / The Netherlands Cancer Institute / Cambridge Center / Wellcome Trust Sanger Institute / University of California San Diego / University of Helsinki / Ludwig Institute / Inn Fields / Hughes Medical Institute / Research UK London Research Institute / Institute of MIT / Courtauld Building / Genomics Institute / Plank Institute of Molecular Cell Biology / /
Inflammatory Diseases / Molecular Carcinogenesis / Cancer / insulinoma cell line / /
Organization
Harvard Medical School / 5Max Plank Institute of Molecular Cell Biology and Genetics / 16Drosophila RNAi Screening Center / Cambridge Center / Massachusetts General Hospital Boston / MIT / Harvard / Ludwig Institute / Genomics Institute / 2Howard Hughes Medical Institute / The Netherlands Cancer Institute / 7Cancer Research UK London Research Institute / Center for Biomedical Genetics / Dana-Farber Cancer Institute / 17Whitehead Institute for Biomedical Research / Department of Genetics / 10Broad Institute / The Johns Hopkins University School of Medicine / Novartis Research Foundation / German Cancer Research Center / Hughes Medical Institute / 9The Wellcome Trust Sanger Institute / 8Gene Expression Unit / University of Helsinki / Southwestern Medical Center / University of California San Diego / /
Position
advocate / /
ProvinceOrState
Texas / Maryland / Washington / California / Massachusetts / /
© 2006 Nature Publishing Group http://www.nature.com/naturemethods COMMENTARY Minimizing the risk of reporting false positives in large-scale RNAi screens